GlycoMar is a biotechnology company discovering and developing products for the healthcare and personal care markets.
The company, founed in 2005, has an established discovery platform technology based on marine natural products, which generates valuable intellectual property.
GlycoMar is developing novel pharmaceutical products for the treatement of inflammatory disorders such as psoriasis, asthma, and inflammatory bowel disease. The company is also developing cosmetic ingredients for the skincare market. Our development programme is being carried out both in house and with commecial partners.
For more information on the biotechnology industry visit biotechnologycompanies.net.